Koyfin Home > Directory > Health Care > Antares Pharma > Net Income Margin

Antares Pharma Net Income Margin Chart (ATRS)

Antares Pharma annual/quarterly Net Income Margin from 2001 to 2018. Net profit margin, or net margin, is equal to net income or profits divided by total revenue and represents how much profit each dollar of sales generates. Net profit margin is the ratio of net profits or net income to revenues for a company.
  • Antares Pharma Net Income Margin for the quarter ending December 12, 2018 was $33m a 249.59% increase of 81m year over year
  • Antares Pharma Net Income Margin for the last 12 months ending December 12, 2018 was $-10m a -221.57% increase of 23m year over year
  • Antares Pharma Annual Net Income Margin for 2018 was $-10m a -199.60% increase of 20m from 2017
  • Antares Pharma Annual Net Income Margin for 2017 was $-31m a -51.75% increase of 16m from 2016
  • Antares Pharma Annual Net Income Margin for 2016 was $-47m a 2.92% decrease of -1m from 2015
Other Margins & Efficiency Metrics:
  • Antares Pharma EBITDA Margin for the quarter ending December 12, 2018 was $-27m a -45.38% increase of 12m year over year
  • Antares Pharma Return on Capital % for the quarter ending December 12, 2018 was -25.15 a -0.12% increase of 0.03 year over year
  • Antares Pharma Return on Equity % for the quarter ending December 12, 2018 was 77.43 a 203.55% increase of 157.61 year over year
View Chart On Koyfin

Quarterly ATRS Net Income Margin Data

12/2018$33m
09/2018$-11m
06/2018$-32m
03/2018$-49m
12/2017$-26m
09/2017$-36m
06/2017$-21m
03/2017$-39m
12/2016$-32m
09/2016$-45m

Annual ATRS Net Income Margin Data

2018$-10m
2017$-31m
2016$-47m
2015$-45m
2014$-133m
2013$-99m
2012$-51m
2011$-27m
2010$-48m
2009$-124m